Artivion Corp (AORT) Long-Term Liabilities to Equity

Artivion, Inc. (AORT) relies on a network of cryogenic hubs for the flawless delivery of bio-implants, which supports high margins. In the cardiac surgery segment, the company faces the acquisition of startups by industry behemoths. Demand for aortic solutions in cardiac centers is growing, and the indicator stands at 0.96. This price action chart (separate_debt_long_eq), which serves as confirmation of the market valuation, is presented below.

This indicator measures the ratio of liabilities with a maturity of more than one year to equity, determining the degree of financial stability and the company's dependence on external borrowing. By analyzing the long-term debt-to-equity coverage ratio, investors assess the balance between debt load and capital, which is critical for Artivion, Inc. (AORT) amid stable demand for high-tech cardiovascular surgical products.